License and royalty-free antibody discovery against any target
Aldevron delivers advanced antibody discovery solutions for the most difficult targets. Our Genovac immunization technologies combined with our two single B cell platforms and highly efficient hybridoma technology provide robust delivery of antibodies for therapeutic, diagnostic and R&D applications.
As an approved contract research partner of the leading transgenic animal providers, Aldevron can rapidly develop humanized antibodies against the most challenging targets such as GPCRs and ion channels.
The delivery of advanced immunization technologies, two automated single B cell platforms, highly efficient hybridoma, transgenic animal partnerships on a fee for service basis is the Aldevron Advantage.